CA109527/CA/NCI NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
2006	2
2007	1
2008	5
2009	2
2010	2
2011	6
2012	1
2013	2
2014	4
2015	5
2016	2
2017	1
2018	2
2020	3
2021	6
2022	0

1

Molecular and Cellular Factors Associated with Racial Disparity in Breast Cancer.

Charan M, Verma AK, Hussain S, Misri S, Mishra S, Majumder S, Ramaswamy B, Ahirwar D, Ganju RK. Charan M, et al. Int J Mol Sci. 2020 Aug 18;21(16):5936. doi: 10.3390/ijms21165936. Int J Mol Sci. 2020. PMID: 32824813 Free PMC article. Review.

2

The Roles of Stroma-Derived Chemokine in Different Stages of Cancer Metastases.

Hussain S, Peng B, Cherian M, Song JW, Ahirwar DK, Ganju RK. Hussain S, et al. Front Immunol. 2020 Dec 22;11:598532. doi: 10.3389/fimmu.2020.598532. eCollection 2020. Front Immunol. 2020. PMID: 33414786 Free PMC article. Review.

3

Contribution of the tumor and obese microenvironment to triple negative breast cancer.

Kaul K, Misri S, Ramaswamy B, Ganju RK. Kaul K, et al. Cancer Lett. 2021 Jul 1;509:115-120. doi: 10.1016/j.canlet.2021.03.024. Epub 2021 Mar 30. Cancer Lett. 2021. PMID: 33798632 Review.

4

Racially Disparate Expression of mTOR/ERK-1/2 Allied Proteins in Cancer.

Mishra S, Charan M, Verma AK, Ramaswamy B, Ahirwar DK, Ganju RK. Mishra S, et al. Front Cell Dev Biol. 2021 Apr 30;9:601929. doi: 10.3389/fcell.2021.601929. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33996789 Free PMC article. Review.

5

Non-contact method for directing electrotaxis.

Ahirwar DK, Nasser MW, Jones TH, Sequin EK, West JD, Henthorne TL, Javor J, Kaushik AM, Ganju RK, Subramaniam VV. Ahirwar DK, et al. Sci Rep. 2015 Jun 9;5:11005. doi: 10.1038/srep11005. Sci Rep. 2015. PMID: 26055698 Free PMC article.

6

Slit2-Mediated Metabolic Reprogramming in Bone Marrow-Derived Macrophages Enhances Antitumor Immunity.

Kaul K, Benej M, Mishra S, Ahirwar DK, Yadav M, Stanford KI, Jacob NK, Denko NC, Ganju RK. Kaul K, et al. Front Immunol. 2021 Oct 28;12:753477. doi: 10.3389/fimmu.2021.753477. eCollection 2021. Front Immunol. 2021. PMID: 34777365 Free PMC article.

7

Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer.

Charan M, Das S, Mishra S, Chatterjee N, Varikuti S, Kaul K, Misri S, Ahirwar DK, Satoskar AR, Ganju RK. Charan M, et al. Cell Death Dis. 2020 Sep 17;11(9):774. doi: 10.1038/s41419-020-02992-y. Cell Death Dis. 2020. PMID: 32943608 Free PMC article.

8

Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation.

Ahirwar DK, Nasser MW, Ouseph MM, Elbaz M, Cuitiño MC, Kladney RD, Varikuti S, Kaul K, Satoskar AR, Ramaswamy B, Zhang X, Ostrowski MC, Leone G, Ganju RK. Ahirwar DK, et al. Oncogene. 2018 Aug;37(32):4428-4442. doi: 10.1038/s41388-018-0263-7. Epub 2018 May 3. Oncogene. 2018. PMID: 29720724 Free PMC article.

9

TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer.

Elbaz M, Ahirwar D, Xiaoli Z, Zhou X, Lustberg M, Nasser MW, Shilo K, Ganju RK. Elbaz M, et al. Oncotarget. 2016 May 27;9(71):33459-33470. doi: 10.18632/oncotarget.9663. eCollection 2018 Sep 11. Oncotarget. 2016. PMID: 30323891 Free PMC article.

10

Slit2 Inhibits Breast Cancer Metastasis by Activating M1-Like Phagocytic and Antifibrotic Macrophages.

Ahirwar DK, Charan M, Mishra S, Verma AK, Shilo K, Ramaswamy B, Ganju RK. Ahirwar DK, et al. Cancer Res. 2021 Oct 15;81(20):5255-5267. doi: 10.1158/0008-5472.CAN-20-3909. Epub 2021 Aug 16. Cancer Res. 2021. PMID: 34400395

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results